Quality of Life in Children With Psychiatric Disorders and Parental Well-being: Effects of Group CBT

Sponsor
Helsinki University Central Hospital (Other)
Overall Status
Completed
CT.gov ID
NCT05808114
Collaborator
(none)
109
2
42

Study Details

Study Description

Brief Summary

This study examines the immediate and long-term effectiveness of a group cognitive behavioral therapy intervention (GCBT) in improving health-related quality of life (HRQOL) in children treated for mixed psychiatric disorders in naturalistic child psychiatric outpatient settings. The effects of a treatment-as-usual condition (TAU) is also examined. Further, the study aims to explore the associations among children´s HRQOL dimensions and parental well-being, and how GCBT may influence these associations.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: Friends program
  • Behavioral: TAU
N/A

Detailed Description

The effectiveness of GCBT and TAU at the different time points are measured using nonparametric tests, such as Friedman tests and Wilcoxon tests. The associations among children´s HRQOL dimensions and parental well-being variables at different time points are explored using a network analysis approach.

Study Design

Study Type:
Interventional
Actual Enrollment :
109 participants
Allocation:
Non-Randomized
Intervention Model:
Parallel Assignment
Masking:
None (Open Label)
Primary Purpose:
Treatment
Official Title:
Quality of Life in Children With Psychiatric Disorders and Parental Well-being: Effects of Group CBT
Actual Study Start Date :
Jul 1, 2016
Actual Primary Completion Date :
Dec 31, 2019
Actual Study Completion Date :
Dec 31, 2019

Arms and Interventions

Arm Intervention/Treatment
Experimental: Group cognitive behavioral therapy

Friends Program

Behavioral: Friends program
A GCBT intervention comprising ten weekly 60-minute sessions followed by two booster sessions

Experimental: Treatment as Usual

A TAU condition during which participants received routine care services tailored to each child individually.

Behavioral: TAU
Individually tailored and delivered specialized child psychiatric care

Outcome Measures

Primary Outcome Measures

  1. Changes in self-and parent-rated health-related quality of life after the group cognitive behavior therapy (GCBT) intervention [Before and after the group cognitive behavioral intervention (duration from pre-GCBT to post-GCBT circa 4.7 months), and at a 7-month follow-up]

    Children´s health-related quality of life measured using the KINDL-R measure, total scores range from 0-100 with higher scores indicating better health-related quality of life

  2. Changes in self-and parent-rated health-related quality of life after treatment as usual (TAU) [Before and after TAU (duration circa 3.2 months)]

    Children´s health-related quality of life measured using the KINDL-R measure, total scores range from 0-100 with higher scores indicating better health-related quality of life

Secondary Outcome Measures

  1. Associations among children´s health-related quality of life and parental well-being dimensions [Before and after the group cognitive behavioral intervention (duration from pre-GCBT to post-GCBT circa 4.7 months), and at a 7-month follow-up]

    Children´s health-related quality of life measured using the KINDL-R measure, total scores range from 0-100 with higher scores indicating better health-related quality of life

  2. Associations among children´s HRQOL and parental well-being dimensions (parental psychological distress) [Before and after the group cognitive behavioral intervention (duration from pre-GCBT to post-GCBT circa 4.7 months), and at a 7-month follow-up]

    Parental psychological distress measured using five items of the 12-item General Health Questionnaire. The sum of the items range from 5-20 with higher scores indicating greater psychological distress

  3. Associations among children´s HRQOL and parental well-being dimensions (parental sleep disturbance) [Before and after the group cognitive behavioral intervention (duration from pre-GCBT to post-GCBT circa 4.7 months), and at a 7-month follow-up]

    Parental sleep disturbance measured using the four- item Jenkins Sleep Questionnaire. Scores range from 0-20 with higher scores indicating greater sleep disturbance

Eligibility Criteria

Criteria

Ages Eligible for Study:
6 Years to 13 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • child psychiatric outpatient care

  • sufficient skills to participate in group sessions

Exclusion Criteria:
  • child psychiatric inpatient care

  • acute suicidality

  • excessive physical aggression

Contacts and Locations

Locations

No locations specified.

Sponsors and Collaborators

  • Helsinki University Central Hospital

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Sarianna Barron-Linnankoski, Principal Investigator, Helsinki University Central Hospital
ClinicalTrials.gov Identifier:
NCT05808114
Other Study ID Numbers:
  • HUS/2699/2018
First Posted:
Apr 11, 2023
Last Update Posted:
Apr 11, 2023
Last Verified:
Mar 1, 2023
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Sarianna Barron-Linnankoski, Principal Investigator, Helsinki University Central Hospital
Additional relevant MeSH terms:

Study Results

No Results Posted as of Apr 11, 2023